Scynexis: A Novel Antifungal Drug Against Life-Threatening Resistant Infections And Ridiculously Cheap Valuation

JERSEY CITY, N.J., Nov. 12, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today reported financial results for the .....»»

A nasal spray sold under the CVS Health brand is being recalled because it may lead to life-threatening infections for certain patients, according to the Food and Drug Administration. .....»»

­JERSEY CITY, N.J., Nov. 13, 2018 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today reported financial results for .....»»

Venatorx Pharmaceuticals, a Malvern company specializing in antibiotics, has formed a multimillion-dollar partnership with a nonprofit that develops new treatments for drug-resistant infections. Under the collaboration, the Global Antibiotic Res.....»»

More than 2.8 million infections and 35,000 deaths each year are caused by antibiotic-resistant bacteria and fungi, The Centers for Disease Control and Prevention said Wednesday in a new report. That's at least one infection every 11 seconds and one deat.....»»

Fungus Candida auris has cropped up simultaneously in far corners of the world — atypical behavior for a spreading fungus that usually radiates from one location, leading scientists to theorize that global warming is in part responsible......»»

Viela Bio Inc. has earned a breakthrough therapy designation from the Food and Drug Administration for a product to treat neuromyelitis optica spectrum disorder, a life-threatening autoimmune disease that impacts the central nervous system. The FDA g.....»»

Viela Bio Inc. has earned a breakthrough therapy designation from the Food and Drug Administration for a product to treat neuromyelitis optica spectrum disorder, a life-threatening autoimmune disease that impacts the central nervous system. The FDA g.....»»

Alibaba Group Holding Limited (NYSE:BABA) Is Ridiculously Cheap Using any basic valuation technique, Alibaba is a steal. Any discounted cash flow model suggests upside barring a massive deceleration in cash flow growth. And on a P/E.....»»

The Food and Drug Administration approved the first generic version from a rival company of Mylan’s EpiPen injector device for life-threatening allergic reactions.....»»

King Bio said the use of the medicines, produced between Aug. 1, 2017 and April 2018, could result in life-threatening infections .....»»

Beware food and beverages made with liquid nitrogen. The U.S. Food and Drug Administration .....»»

FortuneThe FDA Just Issued a Life-Threatening Warning About Ice Cream, Cereal and Cocktails—ReallyFortuneThe U.S. Food and Drug Administration (FDA) h.....»»

An experimental drug derived from peanuts protected some children and adolescents with life-threatening peanut allergies, according to a study, allowing the subjects to eat small amounts of peanuts without suffering a serious reaction......»»

The technology can sense the critical moment a drug user's breaths drop to life-threatening levels......»»

Before COVID-19 was even a part of our vocabulary, the CDC had long been monitoring a different, increasingly urgent threat. .....»»

‘I blocked my ex-in-laws, and now I received a threatening voicemail from a blocked number, so I’ve taken it upon myself to notify the authorities.’.....»»

Insider profiled Michael Rubin, Fanatics executive chairman and Philadelphia 76ers partner, following Fanatics' recent $12.8 billion valuation. Robert Kraft, Jay-Z, and.....»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

A drug-discovery company CEO, a life science real estate broker, and a biotech trade association leader share what they see as the state of the industry in New York City and where they predict it goes from here. Watch the full panel discussion......»»